Allogeneic hematopoietic SCT (HCT) offers potentially curative therapy for patients with hematologic malignancies, but also carries significant risks. Assessing potential risk versus benefit is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback